Cumulative events and incidence of events during follow-up in patients without OAC at baseline (N = 1,541).

Use of Chronic Oral Anticoagulation and Associated Outcomes Among Patients Undergoing Percutaneous Coronary Intervention

Secemsky, Eric A.
Butala, Neel M.
Kartoun, Uri
Mahmood, Sadiqa
Wasfy, Jason H.
Kennedy, Kevin F.
Shaw, Stanley Y.
Yeh, Robert W.

January 2017

Background: Contemporary rates of oral anticoagulant (OAC) therapy and associated outcomes among pat...

Incidence of adverse events during on-treatment follow-up and whole study period.

Young-Jun Rhie (6708275)
Jae-Ho Yoo (6708278)
Jin-Ho Choi (288185)
Hyun-Wook Chae (6708281)
Jae Hyun Kim (665252)
Sochung Chung (6708284)
Il Tae Hwang (6708287)
Choong Ho Shin (841540)
Eun Young Kim (132204)
Ho-Seong Kim (286495)

May 2019

Incidence of adverse events during on-treatment follow-up and whole study period.</p

Cumulative incidence of AF following acute PE.

Austin Chin Chwan Ng (404520)
Dona Adikari (2548372)
David Yuan (2548369)
Jerrett K. Lau (2548375)
Andy Sze Chiang Yong (404522)
Vincent Chow (404521)
Leonard Kritharides (277594)

March 2016

The graph shows cumulative proportions of patients in percentages who developed subsequent atrial...

Comparison of baseline characteristics and co-morbidities between patients with and without OAC at baseline.

Yasuhiro Hamatani (822612)
Yugo Yamashita (822613)
Masahiro Esato (52338)
Yeong-Hwa Chun (822614)
Hikari Tsuji (822615)
Hiromichi Wada (337134)
Koji Hasegawa (337158)
Mitsuru Abe (337148)
Gregory Y. H. Lip (195779)
Masaharu Akao (233558)

November 2015

Categorial data are presented as number (%). Continuous data are presented as mean ± standard dev...

Cumulative incidence curves of outcomes for patients according to initiated treatment before and after propensity score weighting method.

Yi-Hsin Chan (843243)
Kuang-Tso Lee (6475643)
Yi-Wei Kao (6421310)
Chien-Ying Huang (6475646)
Yung-Lung Chen (647296)
Samuel Chi-Ling Hang (6475649)
Pao-Hsien Chu (344527)

March 2019

The NOAC and warfarin groups both showed a lower cumulative risk of efficacy outcomes compared with ...

Cumulative rate of follow-up all-cause mortality (A) or major adverse cardiovascular events (B) in patients initially treated with rosuvastatin or atorvastatin.

Yong Liu (6908)
Yuan-hui Liu (652076)
Ning Tan (547708)
Ji-yan Chen (626581)
Ying-ling Zhou (626587)
Li-wen Li (626583)
Chong-yang Duan (652077)
Ping-Yan Chen (467931)
Jian-fang Luo (652078)
Hua-long Li (652079)
Wei-Guo (652080)

October 2014

Cumulative rate of follow-up all-cause mortality (A) or major adverse cardiovascular events (B) i...

Adverse events in patients on self-managed oral anticoagulant therapy (N = 2068).

Hanna Nilsson (664308)
Erik Lerkevang Grove (447768)
Torben Bjerregaard Larsen (664309)
Peter Brønnum Nielsen (664310)
Flemming Skjøth (664311)
Marianne Maegaard (664312)
Thomas Decker Christensen (664313)

November 2014

*) Includes traumatic and non-traumatic intracranial bleeding.Abbreviations:N: Numb...

Cumulative incidence of discontinuation among newly anticoagulated non-valvular atrial fibrillation patients.

Gregory Y. H. Lip (195779)
Xianying Pan (4801356)
Shital Kamble (5154890)
Hugh Kawabata (5154365)
Jack Mardekian (88174)
Cristina Masseria (453142)
Hemant Phatak (444121)

April 2018

(Upper panel) Cumulative incidence of discontinuation during the follow-up period. The unadjusted...

Thrombotic events during oral anticoagulant treatment: results of the inception cohort prospective collaborative ISCOAT study

Palareti, G
Manotti, C
D'Angelo, A
Pengo, Vittorio
Erba, N
Moia, M
Ciavarella, N
Devoto, G
Berrettini, M
Leali, N
Poggi, M
Legnani, C.

January 1997

The paper reports on rate and type of thrombotic events occurring during the observational, prospect...

Cumulative incidence and hazard ratios of stroke/systemic embolism among 5 mg BID apixaban/warfarin patients.

Xiaoyan Li (117291)
Allison Keshishian (2582335)
Melissa Hamilton (173102)
Ruslan Horblyuk (4801353)
Kiran Gupta (4042460)
Xuemei Luo (65327)
Jack Mardekian (88174)
Keith Friend (4801350)
Anagha Nadkarni (4801347)
Xianying Pan (4801356)
Gregory Y. H. Lip (195779)
Steve Deitelzweig (4801359)

January 2018

(A) Cumulative incidence of stroke/SE among propensity-score–matched 5 mg BID apixaban and...

Cumulative incidence of OA in ACL-injured patients with and without reconstruction.

Sheng-Hsiung Lin (3095811)
Ting-Chuan Wang (4054249)
Chun-Fu Lai (141724)
Ru-Yin Tsai (344728)
Chih-Ping Yang (1694320)
Chih-Shung Wong (3095808)

May 2017

Cumulative incidence of OA in ACL-injured patients with and without reconstruction.</p

Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy.

Rubboli, A.
Becattini, C.
Verheugt, F.W.A.

January 2011

Bleeding is the most important complication of oral anticoagulation (OAC) with vitamin K-antagonists...

Cumulative incidence of total major adverse cardiovascular event (MACE) according to the presence of hypertensive event in ED.

Sihyoung Lee (4856605)
Chang-youn You (4856602)
Joonghee Kim (4856608)
You Hwan Jo (4856611)
Young Sun Ro (2623285)
Si-Hyuck Kang (281491)
Heeyoung Lee (700523)

February 2018

Cumulative incidence of total major adverse cardiovascular event (MACE) according to the presence...

The adjusted risk of outcomes for those patients taking oral anticoagulants in relative to no-treatment according to NOAC and warfarin with different TTR.

Yi-Hsin Chan (843243)
Kuang-Tso Lee (6475643)
Yi-Wei Kao (6421310)
Chien-Ying Huang (6475646)
Yung-Lung Chen (647296)
Samuel Chi-Ling Hang (6475649)
Pao-Hsien Chu (344527)

March 2019

The adjusted risk of outcomes for those patients taking oral anticoagulants in relative to no-treatm...

Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT‐AF

O'Brien, Emily C
Holmes, DaJuanicia N
Thomas, Laine
Fonarow, Gregg C
Kowey, Peter R
Ansell, Jack E
Mahaffey, Kenneth W
Gersh, Bernard J
Peterson, Eric D
Piccini, Jonathan P
Hylek, Elaine M

June 2018

Oral anticoagulation (OAC) reduces stroke risk in atrial fibrillation, but bleeding is a frequent si...

Use of Chronic Oral Anticoagulation and Associated Outcomes Among Patients Undergoing Percutaneous Coronary Intervention

Secemsky, Eric A.
Butala, Neel M.
Kartoun, Uri
Mahmood, Sadiqa
Wasfy, Jason H.
Kennedy, Kevin F.
Shaw, Stanley Y.
Yeh, Robert W.

January 2017

Background: Contemporary rates of oral anticoagulant (OAC) therapy and associated outcomes among pat...

Incidence of adverse events during on-treatment follow-up and whole study period.

Young-Jun Rhie (6708275)
Jae-Ho Yoo (6708278)
Jin-Ho Choi (288185)
Hyun-Wook Chae (6708281)
Jae Hyun Kim (665252)
Sochung Chung (6708284)
Il Tae Hwang (6708287)
Choong Ho Shin (841540)
Eun Young Kim (132204)
Ho-Seong Kim (286495)

May 2019

Incidence of adverse events during on-treatment follow-up and whole study period.</p

Cumulative incidence of AF following acute PE.

Austin Chin Chwan Ng (404520)
Dona Adikari (2548372)
David Yuan (2548369)
Jerrett K. Lau (2548375)
Andy Sze Chiang Yong (404522)
Vincent Chow (404521)
Leonard Kritharides (277594)

March 2016

The graph shows cumulative proportions of patients in percentages who developed subsequent atrial...

Comparison of baseline characteristics and co-morbidities between patients with and without OAC at baseline.

Yasuhiro Hamatani (822612)
Yugo Yamashita (822613)
Masahiro Esato (52338)
Yeong-Hwa Chun (822614)
Hikari Tsuji (822615)
Hiromichi Wada (337134)
Koji Hasegawa (337158)
Mitsuru Abe (337148)
Gregory Y. H. Lip (195779)
Masaharu Akao (233558)

November 2015

Categorial data are presented as number (%). Continuous data are presented as mean ± standard dev...

Cumulative incidence curves of outcomes for patients according to initiated treatment before and after propensity score weighting method.

Yi-Hsin Chan (843243)
Kuang-Tso Lee (6475643)
Yi-Wei Kao (6421310)
Chien-Ying Huang (6475646)
Yung-Lung Chen (647296)
Samuel Chi-Ling Hang (6475649)
Pao-Hsien Chu (344527)

March 2019

The NOAC and warfarin groups both showed a lower cumulative risk of efficacy outcomes compared with ...

Cumulative rate of follow-up all-cause mortality (A) or major adverse cardiovascular events (B) in patients initially treated with rosuvastatin or atorvastatin.

Yong Liu (6908)
Yuan-hui Liu (652076)
Ning Tan (547708)
Ji-yan Chen (626581)
Ying-ling Zhou (626587)
Li-wen Li (626583)
Chong-yang Duan (652077)
Ping-Yan Chen (467931)
Jian-fang Luo (652078)
Hua-long Li (652079)
Wei-Guo (652080)

October 2014

Cumulative rate of follow-up all-cause mortality (A) or major adverse cardiovascular events (B) i...

Adverse events in patients on self-managed oral anticoagulant therapy (N = 2068).

Hanna Nilsson (664308)
Erik Lerkevang Grove (447768)
Torben Bjerregaard Larsen (664309)
Peter Brønnum Nielsen (664310)
Flemming Skjøth (664311)
Marianne Maegaard (664312)
Thomas Decker Christensen (664313)

November 2014

*) Includes traumatic and non-traumatic intracranial bleeding.Abbreviations:N: Numb...

Cumulative incidence of discontinuation among newly anticoagulated non-valvular atrial fibrillation patients.

Gregory Y. H. Lip (195779)
Xianying Pan (4801356)
Shital Kamble (5154890)
Hugh Kawabata (5154365)
Jack Mardekian (88174)
Cristina Masseria (453142)
Hemant Phatak (444121)

April 2018

(Upper panel) Cumulative incidence of discontinuation during the follow-up period. The unadjusted...

Thrombotic events during oral anticoagulant treatment: results of the inception cohort prospective collaborative ISCOAT study

Palareti, G
Manotti, C
D'Angelo, A
Pengo, Vittorio
Erba, N
Moia, M
Ciavarella, N
Devoto, G
Berrettini, M
Leali, N
Poggi, M
Legnani, C.

January 1997

The paper reports on rate and type of thrombotic events occurring during the observational, prospect...

Cumulative incidence and hazard ratios of stroke/systemic embolism among 5 mg BID apixaban/warfarin patients.

Xiaoyan Li (117291)
Allison Keshishian (2582335)
Melissa Hamilton (173102)
Ruslan Horblyuk (4801353)
Kiran Gupta (4042460)
Xuemei Luo (65327)
Jack Mardekian (88174)
Keith Friend (4801350)
Anagha Nadkarni (4801347)
Xianying Pan (4801356)
Gregory Y. H. Lip (195779)
Steve Deitelzweig (4801359)

January 2018

(A) Cumulative incidence of stroke/SE among propensity-score–matched 5 mg BID apixaban and...

Cumulative incidence of OA in ACL-injured patients with and without reconstruction.

Sheng-Hsiung Lin (3095811)
Ting-Chuan Wang (4054249)
Chun-Fu Lai (141724)
Ru-Yin Tsai (344728)
Chih-Ping Yang (1694320)
Chih-Shung Wong (3095808)

May 2017

Cumulative incidence of OA in ACL-injured patients with and without reconstruction.</p

Incidence, clinical impact and risk of bleeding during oral anticoagulation therapy.

Rubboli, A.
Becattini, C.
Verheugt, F.W.A.

January 2011

Bleeding is the most important complication of oral anticoagulation (OAC) with vitamin K-antagonists...

Cumulative incidence of total major adverse cardiovascular event (MACE) according to the presence of hypertensive event in ED.

Sihyoung Lee (4856605)
Chang-youn You (4856602)
Joonghee Kim (4856608)
You Hwan Jo (4856611)
Young Sun Ro (2623285)
Si-Hyuck Kang (281491)
Heeyoung Lee (700523)

February 2018

Cumulative incidence of total major adverse cardiovascular event (MACE) according to the presence...

The adjusted risk of outcomes for those patients taking oral anticoagulants in relative to no-treatment according to NOAC and warfarin with different TTR.

Yi-Hsin Chan (843243)
Kuang-Tso Lee (6475643)
Yi-Wei Kao (6421310)
Chien-Ying Huang (6475646)
Yung-Lung Chen (647296)
Samuel Chi-Ling Hang (6475649)
Pao-Hsien Chu (344527)

March 2019

The adjusted risk of outcomes for those patients taking oral anticoagulants in relative to no-treatm...

Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT‐AF

O'Brien, Emily C
Holmes, DaJuanicia N
Thomas, Laine
Fonarow, Gregg C
Kowey, Peter R
Ansell, Jack E
Mahaffey, Kenneth W
Gersh, Bernard J
Peterson, Eric D
Piccini, Jonathan P
Hylek, Elaine M

June 2018

Oral anticoagulation (OAC) reduces stroke risk in atrial fibrillation, but bleeding is a frequent si...

Use of Chronic Oral Anticoagulation and Associated Outcomes Among Patients Undergoing Percutaneous Coronary Intervention

Secemsky, Eric A.
Butala, Neel M.
Kartoun, Uri
Mahmood, Sadiqa
Wasfy, Jason H.
Kennedy, Kevin F.
Shaw, Stanley Y.
Yeh, Robert W.

January 2017

Background: Contemporary rates of oral anticoagulant (OAC) therapy and associated outcomes among pat...

Incidence of adverse events during on-treatment follow-up and whole study period.

Young-Jun Rhie (6708275)
Jae-Ho Yoo (6708278)
Jin-Ho Choi (288185)
Hyun-Wook Chae (6708281)
Jae Hyun Kim (665252)
Sochung Chung (6708284)
Il Tae Hwang (6708287)
Choong Ho Shin (841540)
Eun Young Kim (132204)
Ho-Seong Kim (286495)

May 2019

Incidence of adverse events during on-treatment follow-up and whole study period.</p

Cumulative incidence of AF following acute PE.

Austin Chin Chwan Ng (404520)
Dona Adikari (2548372)
David Yuan (2548369)
Jerrett K. Lau (2548375)
Andy Sze Chiang Yong (404522)
Vincent Chow (404521)
Leonard Kritharides (277594)

March 2016

The graph shows cumulative proportions of patients in percentages who developed subsequent atrial...

Cumulative events and incidence of events during follow-up in patients without OAC at baseline (N = 1,541).

Abstract

Extracted data

Cumulative events and incidence of events during follow-up in patients without OAC at baseline (N = 1,541).

Abstract

Extracted data

Related items

Related items